Dawn F. Ionescu, MD

  • 8Articles
  • 109.7KReads
  • 2014–2022Active
  • 42Collaborators
  • 604Citations

About

Dawn F. Ionescu, MD, is affiliated with Janssen Research & Development in La Jolla, California. Her publications from 2014 to 2022 focus on depression, suicide, and psychiatry, with particular emphasis on the use of ketamine and esketamine for major depressive disorder and suicidal ideation. She has contributed to research on the effects of concomitant benzodiazepines, predictors of ketamine response, and treatments for anxious depression. Frequent collaborators include Cristina Cusin, Erica M. Richards, and Mark J. Niciu.

Publications

JCP
Effect of Benzodiazepines on Antidepressant Effects of Ketamine
Original Research

Effect of Benzodiazepines on Antidepressant Effects of Ketamine

November 14, 2022

Findings of studies examining the impact of benzodiazepines on antidepressant effects of ketamine are contradictory. This study assessed whether concomitant oral benzodiazepines differentially affected treatment response to ketamine versus...
, , , et al
JCP
Original Research

Esketamine Nasal Spray Rapidly Reduces Depression

May 12, 2020

There is an unmet need in patients with depression and active suicidal ideation for new therapies that can rapidly bridge the gap until antidepressants take effect. Read this article...
, , , et al
JCP
Letter to the Editor

Drs Ionescu and Cusin Reply

January 25, 2017

,
JCP
Article

Ketamine for Suicidal Ideation

June 22, 2016

When your treatment-resistant depressed patients are thinking about suicide, what else can you as a clinician do to pull them from the brink of these ideations? Consider whether adjunctive...
, , , et al
JCP
ASCP Corner

Updates and Trends in the Treatment of Major Depressive Disorder

December 24, 2014

,
JCP
Article

Effect of Baseline Anxious Depression on Initial and Sustained Antidepressant Response to Ketamine

September 25, 2014

, , , et al
PCC
Article

Pharmacologic Treatment of Dimensional Anxious Depression: A Review

June 15, 2014

Did you know that anxious symptoms affect about half of patients with depression? In this CME activity from The Primary Care Companion, read about the outcomes and side effect...
, ,
JCP
Original Research

Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression

May 15, 2014

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe